IBD Science for Patients

Weight-Loss Medicines and Crohn’s: Can They Help Your Gut?

You’ve likely seen many news stories lately about a new generation of weight-loss and diabetes medicines called GLP-1 receptor agonists (popular brands include Ozempic, Wegovy, and Mounjaro). While these drugs are famous for helping people manage their weight, scientists are now discovering they might have a surprising “side effect” for people living with Crohn’s disease: they could help keep the gut calm and reduce the need for strong medications.

What Does the Research Show?

A large, real-world cohort study followed adults who had both Crohn’s disease and obesity. Because this was a “real-world” study, researchers looked at medical data from a vast number of patients in the community rather than a small group in a controlled lab.

The results were very encouraging:

  • Lower Steroid Use: Patients taking GLP-1 medicines were significantly less likely to need corticosteroids (strong anti-inflammatory steroids) to manage their Crohn’s symptoms.
  • Fewer Hospital Stays: The study found that those on the weight-loss medication had a lower risk of being admitted to hospital for their Crohn’s disease.
  • Safety Confirmed: Despite concerns that weight-loss drugs might cause stomach upset, the research showed that for people with IBD, these medicines are generally safe and do not seem to increase the risk of severe flare-ups.

How Could a Weight-Loss Drug Help Crohn’s?

Scientists believe GLP-1 medicines do more than just tell your brain you are full. The “GLP-1” hormone also appears to have anti-inflammatory properties. By dampening down the overall inflammation in the body that often comes with obesity, these drugs may actually help your primary IBD treatment (like biologics) work more effectively.

Why This Matters to You as a Patient

If you are living with both Crohn’s disease and obesity, this large-scale research is a big step forward in personalised medicine.

  1. Breaking the “Steroid Cycle”: Many patients with Crohn’s find themselves trapped in a cycle of needing steroids, which can cause weight gain as a side effect. Finding a treatment that helps you reduce steroid dependence is a massive win for long-term health.
  2. Managing Two Conditions Together: Instead of taking one set of treatments for weight and another for Crohn’s, your doctor can now look at how these treatments might work together. It opens up a new conversation about managing your weight in a way that specifically supports your gut health.
  3. Confidence in Safety: Many patients worry that adding a new, powerful medicine might “clash” with their IBD. This study provides reassuring evidence from a large number of real-world cases that these medicines can be a safe and helpful addition to your care plan.

Explore the Research

Leave a comment